Masashi Nomura
@masashi-nomura.bsky.social
64 followers 39 following 13 posts
Physician scientist, Glioma single-cell genomics researcher, Neurosurgeon @Tokyo University, Postdoc in Suva lab @MGH/Broad
Posts Media Videos Starter Packs
Reposted by Masashi Nomura
avishayspitzer.bsky.social
14/ Big thanks also to the institutions that provided tumor samples @dukepress.bsky.social, @mdanderson.bsky.social, Tokyo University Hospital, Pitié-Salpêtrière Hospital, St. Michael's Hospital, Seoul National University and NORLUX and funders NIH, NCI, Mark Foundation and Sontag Foundation.
Reposted by Masashi Nomura
avishayspitzer.bsky.social
13/ @weizmanninstitute.bsky.social, Mass General Brigham (Cancer Center, Pathology), @broadinstitute.org, @yalepress.bsky.social and University of Miami.
Reposted by Masashi Nomura
avishayspitzer.bsky.social
12/ Big thanks to the PIs that supervised the project @itaytirosh.bsky.social, @suvalab.bsky.social, @roelverhaak.bsky.social, Antonio Iavarone and Anna Lasorella, all collaborators and institutions involved in the CARE consortium >
Reposted by Masashi Nomura
avishayspitzer.bsky.social
4/ And now for the results! Across the cohort the most consistent change at recurrence was reduced malignant cell fraction, with a reciprocal increase in glial and neuronal TME cells. This was observed in ~66% of patients, suggesting increased tumor integration into brain tissue.
masashi-nomura.bsky.social
I thank my great mentor/boss @suvalab.bsky.social and outstanding co-PIs @itaytirosh.bsky.social, @roelverhaak.bsky.social, Antonio Iavarone and Anna Lasorella. Also appreciate all collaborators, patients and their families who generously provided the samples.
masashi-nomura.bsky.social
12/ Before that, I would like to say thank wonderful co-first authors/friends, @avishayspitzer.bsky.social, @kevin-johnson.bsky.social and Luciano Garofano.
masashi-nomura.bsky.social
11/ How this architecture evolves during progression from primary to recurrent GBM is addressed in the second paper, that will be introduced by @avishayspitzer.bsky.social in the following threads later.
masashi-nomura.bsky.social
10/ These three layers of heterogeneity are inter-related and partially associated with specific genetic aberrations, thereby defining three stereotypic ecosystems in GBM. This work provides an unparalleled view of the multi-layered transcriptional architecture of GBM.
masashi-nomura.bsky.social
9/ Third, after controlling for the frequencies of cellular states, we find that the remaining variation between GBM samples highlights three baseline gene expression programs which we labeled Neuronal, Glial, and Extracellular Matrix.
masashi-nomura.bsky.social
8/ Second, we describe the diversity of cellular states and their pathway-based functional activities, with an expanded set of malignant cell states, including glial progenitor cell-like, neuronal-like, and cilia-like states that were previously depleted by tumor dissociation
masashi-nomura.bsky.social
7/ First, GBMs can be classified by their broad cellular composition, encompassing malignant, immune, vascular, neuronal, and glial cell types.
masashi-nomura.bsky.social
6/ In the first paper, we intensively analyzed GBM cellular heterogeneity, irrespective of time points. Our analyses reveled three transcriptomic layers that contribute to GBM heterogeneity.
masashi-nomura.bsky.social
5/ We divided the findings derived from this large-scale dataset into two papers.
masashi-nomura.bsky.social
4/ We thank @mdanderson.bsky.social, @dukecancer.bsky.social, @uoft.bsky.social, @pitiesalpetriere.bsky.social, NORLUX Neuro-Oncology laboratory, Seoul National University and @utokyoofficial.bsky.social for providing precious primary and recurrent GBM cohorts.
masashi-nomura.bsky.social
3/ In these studies, we collected 121 longitudinal GBM samples from 6 countries under GBM CARE (Cellular Analysis of Resistance and Evolution) consortium, and profiled them by single-nucleus RNA-seq (total 420 k cells).
masashi-nomura.bsky.social
2/These are the fantastic collaborative effort between Suva, Tirosh, Verhaak and Iavarone/Lasorella labs. We appreciate all supports from Mass General Brigham (Cancer Center, Pathology), @broadinstitute.org, Weizmann Institute of Science, @yalepress.bsky.social and University of Miami.